SYK - Stryker Corporation
NEXT EARNINGS:
May 7, 2026
EPS Est: $3.00
|
Rev Est: $6.4B
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$424.92
DETAILS
HIGH:
$469.00
LOW:
$390.00
MEDIAN:
$419.00
CONSENSUS:
$424.92
UPSIDE:
11.43%
Market Cap:
145.93B
Volume:
1,290,988
Avg Volume:
1,885,726
52 Week Range:
329.16-404.87
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
0.87
Last Dividend:
$3.40
Exchange:
NYSE
Country:
US
Employees:
53,000
IPO Date:
1980-03-17
EPS (TTM):
8.49
P/E Ratio:
41.38
Revenue (TTM):
25.12B
Total Assets:
47.84B
Total Debt:
14.86B
Cash & Equiv:
4.01B
Rev Growth (5Y):
11.8%
EPS Growth (5Y):
14.8%
FCF Growth (5Y):
9.0%
ROCE:
12.8%
Debt/Equity:
0.66
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-01-29 | $4.47 | $4.40 | +1.6% | $7.2B | $7.1B | +0.7% |
| 2025-10-30 | $3.19 | $3.13 | +1.9% | $6.1B | $6.0B | +0.2% |
| 2025-07-31 | $3.13 | $3.07 | +2.0% | $6.0B | $5.9B | +1.4% |
| 2025-05-01 | $2.84 | $2.71 | +4.8% | $5.9B | $5.7B | +3.1% |
| 2025-01-28 | $4.01 | $3.87 | +3.6% | $6.4B | $6.4B | +1.2% |
| 2024-10-29 | $2.87 | $2.77 | +3.6% | $5.5B | $5.4B | +2.3% |
| 2024-07-30 | $2.81 | $2.79 | +0.7% | $5.4B | $5.4B | +0.3% |
| 2024-04-30 | $2.50 | $2.35 | +6.4% | $5.2B | $5.1B | +2.7% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 25.12B | 22.59B | 20.50B | 18.45B | 17.11B | 14.35B | 14.88B | 13.60B | 12.44B | 11.32B | 9.95B | 9.68B |
| Net Income | 3.25B | 2.99B | 3.17B | 2.36B | 1.99B | 1.60B | 2.08B | 3.55B | 1.02B | 1.65B | 1.44B | 515.00M |
| EPS | 8.49 | 7.86 | 8.34 | 6.23 | 5.29 | 4.26 | 5.57 | 9.50 | 2.73 | 4.40 | 3.82 | 1.36 |
| Total Assets | 47.84B | 42.97B | 39.91B | 36.88B | 34.63B | 34.33B | 30.17B | 27.23B | 22.18B | 20.43B | 16.25B | 17.71B |
| Total Debt | 14.86B | 14.12B | 13.49B | 13.53B | 12.90B | 14.43B | 11.48B | 9.86B | 7.22B | 6.91B | 4.00B | 3.97B |
| Cash & Equivalents | 4.01B | 3.65B | 2.97B | 1.84B | 2.94B | 2.94B | 4.34B | 3.62B | 2.54B | 3.32B | 3.38B | 1.79B |
| Operating Cash Flow | 5.04B | 4.24B | 3.71B | 2.62B | 3.26B | 3.28B | 2.19B | 2.61B | 1.56B | 1.92B | 899.00M | 1.78B |
| Free Cash Flow | 4.28B | 3.49B | 3.14B | 2.04B | 2.74B | 2.79B | 1.54B | 2.04B | 961.00M | 1.43B | 629.00M | 1.55B |
| FCF per Share | 11.21 | 9.15 | 8.26 | 5.38 | 7.26 | 7.43 | 4.12 | 5.45 | 2.57 | 3.81 | 1.67 | 4.09 |
| Book Value | 22.42B | 20.63B | 18.59B | 16.62B | 14.88B | 13.08B | 12.81B | 11.73B | 9.97B | 9.55B | 8.51B | 8.60B |
| Cash & ST Investments | 4.10B | 4.49B | 3.05B | 1.93B | 3.02B | 3.02B | 4.42B | 3.70B | 2.79B | 3.38B | 4.08B | 5.00B |
| ROC Equity | 0.14 | 0.15 | 0.17 | 0.14 | 0.13 | 0.12 | 0.16 | 0.30 | 0.10 | 0.17 | 0.17 | 0.06 |